Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota-A Narrative Review

被引:13
|
作者
Krela-Kazmierczak, Iwona [1 ]
Zakerska-Banaszak, Oliwia [2 ]
Skrzypczak-Zielinska, Marzena [2 ]
Lykowska-Szuber, Liliana [1 ]
Szymczak-Tomczak, Aleksandra [1 ]
Zawada, Agnieszka [1 ]
Rychter, Anna Maria [1 ,3 ]
Ratajczak, Alicja Ewa [1 ,3 ]
Skoracka, Kinga [1 ,3 ]
Skrzypczak, Dorota [1 ]
Marcinkowska, Emilia [1 ]
Slomski, Ryszard [2 ]
Dobrowolska, Agnieszka [1 ]
机构
[1] Poznan Univ Med Sci, Dept Gastroenterol Dietet & Internal Med, PL-60355 Poznan, Poland
[2] Polish Acad Sci, Inst Human Genet, PL-60479 Poznan, Poland
[3] Poznan Univ Med Sci, Doctoral Sch, PL-61701 Poznan, Poland
关键词
IBD; Western diet; Mediterranean diet; microbiota; nutrients; risk factors of IBD; POLYUNSATURATED FATTY-ACIDS; REGULATORY T-CELLS; ULCERATIVE-COLITIS; CROHNS-DISEASE; GUT MICROBIOTA; MEDITERRANEAN DIET; INTESTINAL INFLAMMATION; ANTIBIOTIC USE; RISK-FACTORS; FAECALIBACTERIUM-PRAUSNITZII;
D O I
10.3390/nu14122520
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Despite the increasing knowledge with regard to IBD (inflammatory bowel disease), including ulcerative colitis (UC) and Crohn's disease (CD), the etiology of these conditions is still not fully understood. Apart from immunological, environmental and nutritional factors, which have already been well documented, it is worthwhile to look at the possible impact of genetic factors, as well as the composition of the microbiota in patients suffering from IBD. New technologies in biochemistry allow to obtain information that can add to the current state of knowledge in IBD etiology.
引用
收藏
页数:28
相关论文
共 28 条
  • [1] Statins and inflammatory bowel disease: Where do we stand?
    Peppas, Spyros
    Piovani, Daniele
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    Bonovas, Stefanos
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 75 : 10 - 14
  • [2] Susceptibility Genes and Overall Pathogenesis of Inflammatory Bowel Disease: Where Do We Stand?
    Fiocchi, Claudio
    DIGESTIVE DISEASES, 2009, 27 (03) : 226 - 235
  • [3] Inflammatory bowel disease pathogenesis: Where are we?
    Fiocchi, Claudio
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 12 - 18
  • [4] Mucosal healing in inflammatory bowel disease: Where do we stand?
    Ha C.
    Kornbluth A.
    Current Gastroenterology Reports, 2010, 12 (6) : 471 - 478
  • [5] The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review
    Aldars-Garcia, Laila
    Marin, Alicia C.
    Chaparro, Maria
    Gisbert, Javier P.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (06) : 1 - 15
  • [6] NONINVASIVE METHODS IN EVALUATION OF INFLAMMATORY BOWEL DISEASE: WHERE DO WE STAND NOW? AN UPDATE
    Turkay, Cansel
    Kasapoglu, Benan
    CLINICS, 2010, 65 (02) : 221 - 231
  • [7] Optimising inflammatory bowel disease surveillance and dysplasia management-Where do we stand?
    Al Bakir, Ibrahim
    Kabir, Misha
    Yalchin, Mehmet
    Hart, Ailsa
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2022, 10 (10) : 1054 - 1062
  • [8] Screening and surveillance methods for dysplasia in inflammatory bowel disease patients: Where do we stand?
    Galanopoulos, Michail
    Tsoukali, Emmanouela
    Gkeros, Filippos
    Vraka, Marina
    Karampekos, Georgios
    Matzaris, Gerassimos J.
    WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY, 2018, 10 (10): : 250 - 258
  • [9] Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?
    Tepasse, Phil-Robin
    Vollenberg, Richard
    Nowacki, Tobias Max
    LIFE-BASEL, 2021, 11 (11):
  • [10] A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis
    Vebr, Marek
    Pomahacova, Renata
    Sykora, Josef
    Schwarz, Jan
    BIOMEDICINES, 2023, 11 (12)